Pain is mediated by functionally distinctive components. It may involve acute high threshold afferent stimuli (thermal, mechanical or chemically damaged tissue), protracted afferent input (long-lasting hyperalgesia) or low-threshold input (allodynia as related to pain from light touch). Behavioral patterns will be associated with the effects of noxious stimulus on excitatory transmitters. Humane studies using mechanical, thermal (cold presser test), audio-evoked potentials, or other noxious stimuli during anesthesia and analgesia provide clues to perception of pain in animals and help us determine guidelines for the clinical relief of animal pain. There is a better understanding of cutaneous somatosensory responses than for deep sensation (e.g., subcutaneous tissue, muscle, bone, visceral. The prevention or treatment of pain can best be accomplished when there is a diagnosis of the neuroanatomical distribution of the pain based on evidence of sensory dysfunction involving a peripheral nerve, plexus, nerve root or central pathway using different modalities for quantitative sensory testing. Anatomical studies have demonstrated that unmyelinated primary afferent fibers contain a variety of neuroactive substances which may be released by high-intensity peripheral stimulation. Fast depolarization of the dorsal horn nociresponsive neurons is mediated by tissue damage. These neuroreceptors may be activated by glutamate, substance P, and neurokinin A. The major ascending pathway relaying nociceptive information relating to pain is the spinothalamic tract. Most of the neurons in this tract are nociceptive or thermoreceptive. The thalamus is the final relay nucleus for all the sensory systems, except olfactory tissue. Injury or disease processes in deeper tissue or visceral areas with extensive innervation may result in pain thresholds not adequately controlled by current available analgesics or at their recommended dosage levels. These issues are complex and diagnosis is even more difficult due to species and breed differences in outward expression to painful insult. Medications can now be targeted for specific receptors. (C) 1998 Elsevier Science B.V. All rights reserved.
